Beruflich Dokumente
Kultur Dokumente
Cera Sanitaryware
Organic growth and changing lifestyle to be the key drivers
Cera Sanitaryware Ltd. (CSL) is the third largest sanitary ware company in the organized sector with about 22% market share in India. The company is engaged into manufacturing sanitary ware and faucet ware (commenced since September 2010) products. The company also markets wellness products, which are majorly outsourced. Owing to the changing lifestyle of people, increasing awareness for improving sanitation coverage, expenditure on sanitary ware has been consistently increasing as a percentage of total construction expenditure, thereby providing significant traction for the sanitary ware sector. CSL is trading at an attractive PE of 7.6x and EV/Sales of 0.9x on FY2013E. We recommend Buy on CSL with a target price of `289, based on target PE of 10x and implied EV/Sales of 1.1x for FY2013E.
BUY
CMP Target Price
Investment Period
Sector Market Cap (` cr) Beta 52 Week High / Low Avg. Daily Volume Face Value (`) BSE Sensex Nifty Reuters Code Bloomberg Code
`220 `289
12 months
Ceramic products 279 0.6 248 / 150 5,070 5 17,503 5,334 CERA.BO CRS.IN
Investment rationale
Increased contribution of sanitary ware towards domestic expenditure
On the back of increasing awareness towards improving sanitation coverage, changing lifestyle of people towards nuclear families, the number of households is increasing, thereby creating robust demand for sanitary ware products. Simultaneously, increased disposable income has led to a shift from the unbranded to branded products. This trend is likely to drive strong growth for the sanitary ware industry going forward.
Shareholding Pattern (%) Promoters MF / Banks / Indian Fls FII / NRIs / OCBs Indian Public / Others 55.0 4.7 3.6 36.7
3m 3.7 20.3
1yr (5.2)
3yr 9.9
39.1 299.6
Key financials
CSL FY2011 FY2012E FY2013E Sales (` cr) 243 296 385 OPM (%) 18.8 18.2 17.2 PAT (` cr) 27 31 37 EPS (`) 22 25 29 ROIC (%) 38 29 24 P/E (x) 10.2 8.9 7.6 P/BV (x) 2.5 2.0 1.6 EV/ EBITDA (x) 6.0 5.9 5.2 EV/ Sales (x) 1.1 1.0 0.9
Twinkle Gosar
Investment rationale
Increased contribution of sanitary ware towards domestic expenditure
Owing to the changing lifestyle of people, the role of sanitary products has advanced from being a necessity to a status statement thus impacting the spending structure of individuals and improving the proportion expended on these basic amenities. Growth in per capita income, leading to a simultaneous increase in the disposable income of people, has been a vital factor supporting the changing lifestyle of people. Also, requirement of personal space and privacy gaining an inevitable place, subsequently leading to nuclear families, have augmented residential figures, thereby increasing demand for sanitary products. This trend is expected to continue, providing sustainable demand visibility for sanitary ware products. Considering Indias dense population, its sanitation coverage is only ~40%. With increasing awareness for improving public health, the sanitary ware segment is expected to witness high attention. Lastly, with aesthetics gaining a significant importance, CSLs initiatives to provide better designs and quality are bound to perk up its top line.
CSL started production at its faucet ware unit at Kadi in September 2010. The company had set up this plant with an initial investment of `10cr, met by internal accruals, with current capacity of 2,500 pieces per day, which would be doubled by FY2014E. Faucets, which accounted for 17% of the companys revenue in FY2010, were mainly outsourced directly through imports from Chinese suppliers or from domestic markets. In-house production of the same is expected to boost the companys top-line going forward.
Advertisement
Commssion expenses
Distribution expenses
FY2008
FY2009
FY2010
FY2011
Company financials
Key assumptions
We expect CSLs expanded sanitary ware capacity to be operational by 1QFY2013E; hence, we have not factored the same in our FY2012 estimates. Following are the other key assumptions used to forecast the companys financials:
Advisory Desk Cera Sanitaryware EBITDA to post a 20% CAGR over FY2011-13E
The companys EBITDA is expected to rise from `46cr in FY2011 to `66cr in FY2013E. However, the companys EBITDA margin is expected to dip from 18.8% in FY2011 to 18.2% in FY2012E and to 17.2% in FY2013E, mainly due to the increase in raw-material cost and transport cost to some extent. CSL is operating at its full capacity currently, thereby benefiting from economies of scale.
Wellness products
CSLs bath ware unit continues to market under the brand name Cera. Imported products such as shower cubicles, shower panels and steal cubicles form part of the units product portfolio, which has helped CSL to grow at a fast pace.
Power unit
CSL has wind farms in Gujarat for captive electricity generation. The installed capacity of the companys wind power unit is 4.97MW. Non-conventional wind power generation for FY2011 was 5,676MWH against 5,965MWH in FY2010. CSLs power requirement is met through electricity generated by its wind power unit and DG sets, which are completely based on natural gas.
As compared to market leader HSIL, CSL has consistently given higher returns of on equity. Considering the expansion and development plans being undertaken by the company, CSLs returns are expected to rise further and valuations are likely to become more attractive on forward basis.
FY2008 FY2009 FY2010 FY2011 139 12 127 127 19.4 47 17.4 9 29.9 6 31.2 19 33.2 25 13.9 106 21 12.7 16.7 5 16 6.4 12.9 3 2 1.9 13 0.8 (0) 16 5 35.3 10 10 10 10.7 7.9 8 8 10.7 1 9 171 11 160 160 25.6 59 26.1 9 1.4 5 (14.1) 22 14.8 36 46.8 132 28 31.2 17.5 6 22 34.5 13.8 4 2 1.2 18 36.8 (1) 20 7 34.2 14 14 14 41.1 8.9 11 11 41.1 1 13 200 9 191 191 19.8 67 12.8 12 31.8 6 27.1 23 3.9 47 29.4 155 36 29.2 18.8 6 30 36.3 15.7 3 2 1.3 27 52.2 (0) 30 10 34.4 20 20 20 39.5 10.4 16 16 39.5 2 18 256 13 243 243 27.0 86 29.6 15 18.8 12 94.3 28 21.1 56 19.4 197 46 26.8 18.8 7 39 30.8 16.1 3 5 2.1 36 32.9 (1) 42 15 35.3 27 27 27 38.4 11.3 22 22 38.4 3 24
FY2012E 311 15 296 296 21.8 110 27.2 18 21.8 15 22.0 40 44.4 59 5.7 242 54 17.7 18.2 10 44 11.8 14.8 4 8 2.7 40 8.9 (1) 49 17 35.3 31 31 31 14.6 10.6 25 25 14.6 3 28
FY2013E 405 20 385 385 30.2 147 33.4 24 30.2 19 25.0 53 32.5 77 30.2 319 66 23.3 17.2 13 53 20.7 13.7 6 9 2.3 47 17.7 (1) 57 20 35.3 37 37 37 16.5 9.5 29 29 16.5 3 33
10
FY2012E FY2013E 6 134 140 57 14 211 173 45 128 3 8 148 13 26 57 53 86 63 211 6 167 173 85 14 272 233 58 175 3 8 187 15 34 72 66 109 78 272
11
Cash flow
Y/E March (` cr) Profit Before Tax Depreciation Interest paid Change in WC Other income Direct taxes paid Others Cash from Operations (Inc)/ Dec in Fixed Assets (Inc)/Dec In Investments Other Income Others Cash from Investing Issue of Equity Inc/(Dec) in Debt Dividend Paid (Incl. Tax) Interest paid Others Cash from Financing Inc/(Dec) in cash Opening cash balance Closing cash balance FY2008 16 5 3 3 (2) (5) (8) 10 (31) 2 7 (21) 0 10 (1) (3) 5 11 11 11 FY2009 20 6 4 (1) (2) (7) (2) 18 (5) 2 (1) (4) 0 (4) (1) (4) 6 (3) 11 11 22 FY2010 30 6 3 (0) (2) (10) (2) 23 (0) 2 (4) (1) 0 (8) (2) (3) 3 (9) 12 22 34 FY2011 FY2012E 42 7 3 (11) (5) (15) (0) 21 (14) 8 5 (26) (28) 3 11 (3) (3) 4 9 2 34 36 49 10 4 (15) (8) (17) (1) 21 (60) 8 (5) (57) 19 (3) (4) 12 (24) 36 13 FY2013E 57 13 6 (14) (9) (20) (1) 32 (60) 9 (1) (52) 28 (3) (6) 2 21 1 13 15
12
Key ratios
Y/E March Valuation Ratio (x) P/E (on FDEPS) P/CEPS P/BV Dividend yield (%) EV/Sales EV/EBITDA EV / Total Assets Per Share Data (`) EPS (Basic) EPS (fully diluted) Cash EPS DPS Book Value DuPont Analysis EBIT margin Tax retention ratio Asset turnover (x) ROIC (Post-tax) Cost of Debt (Post Tax) Leverage (x) Operating ROE Returns (%) ROCE (Pre-tax) Angel ROIC (Pre-tax) ROE Turnover ratios (x) Asset Turnover Inventory / Sales (days) Receivables (days) Payables (days) WC cycle (ex-cash) (days) Solvency ratios (x) Net debt to equity Net debt to EBITDA Int. Coverage (EBIT / Int.) 0.5 1.3 5.2 0.2 0.5 5.5 (0.1) (0.2) 11.8 (0.1) (0.1) 14.4 0.3 0.7 10.7 0.4 0.9 8.6 1.3 67 69 129 65 1.6 61 64 113 54 1.9 60 61 124 46 2.1 65 54 127 52 1.7 65 65 129 61 1.7 64 63 125 60 16.7 20.0 19.1 19.1 22.3 22.0 24.0 31.3 24.9 26.8 38.1 27.4 23.4 29.3 25.0 21.9 24.4 23.4 12.9 0.6 1.3 10.7 5.2 0.5 13.4 13.8 0.7 1.6 14.7 7.4 0.2 16.1 15.7 0.7 2.1 21.2 6.1 (0.1) 20.0 16.1 0.6 2.2 22.4 4.6 (0.1) 21.4 14.8 0.6 1.6 15.2 4.6 0.3 17.9 13.7 0.6 1.6 13.8 4.6 0.4 17.2 8.0 8.0 11.9 0.7 46.1 11.2 11.2 15.9 1.0 55.8 15.7 15.7 20.5 1.2 69.9 21.7 21.7 26.8 2.5 88.2 24.8 24.8 32.7 2.5 110.5 28.9 28.9 39.6 2.5 136.9 27.7 18.6 4.8 0.3 2.4 14.4 2.8 19.6 13.8 3.9 0.4 1.8 10.5 2.4 14.1 10.8 3.2 0.6 1.4 7.5 2.1 10.2 8.2 2.5 0.2 1.1 6.0 1.7 8.9 6.7 2.0 0.2 1.1 5.9 1.5 7.6 5.6 1.6 0.2 0.9 5.2 1.3 FY2008 FY2009 FY2010 FY2011 FY2012E FY2013E
13
DISCLAIMER
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may have investment positions in the stocks recommended in this report.
Disclosure of Interest Statement 1. Analyst ownership of the stock 2. Angel and its Group companies ownership of the stock 3. Angel and its Group companies' Directors ownership of the stock 4. Broking relationship with company covered
Cera Sanitary No No No No
Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors
Ratings (Returns):
14